AQST: Aquestive Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 244.21
Enterprise Value ($M) 205.19
Book Value ($M) -60.16
Book Value / Share -0.61
Price / Book -4.06
NCAV ($M) -73.36
NCAV / Share -0.74
Price / NCAV -3.33

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.34
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.36
Current Ratio 4.68

Balance Sheet (mrq) ($M)
Current Assets 88.22
Assets 101.42
Liabilities 161.58
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 57.56
Operating Income -30.77
Net Income -44.14
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -35.76
Cash from Investing -0.16
Cash from Financing 83.59

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 2.90 -52.66
02-13 13G/A Bratton Douglas K 11.10 -0.40
11-14 13G/A Armistice Capital, Llc 2.93 -29.92
11-08 13G BlackRock, Inc. 6.40 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-14 213,786 954,060 22.41
2025-04-11 301,209 1,234,169 24.41
2025-04-10 344,062 1,211,550 28.40
2025-04-09 715,020 2,317,129 30.86

(click for more detail)

Similar Companies
ANIP – ANI Pharmaceuticals, Inc. APGE – Apogee Therapeutics, Inc.
APLT – Applied Therapeutics, Inc. ARCT – Arcturus Therapeutics Holdings Inc.
ARDX – Ardelyx, Inc.


Financial data and stock pages provided by
Fintel.io